List of companies in Adjuvant Capital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York. | ||||||
54Gene is healthcare startup company providing a genetics testing platform in Africa. It also offers genetic reports on health, nutrition, fitness and weight loss, carrier status, personal traits and ancestry. | ||||||
Excision BioTherapeutics is a company founded in 2015 and headquartered in Philadelphia. | ||||||
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract. | ||||||
Producer of fortified packaged food products intended to provide nutrition to low and middle-income households in frontier markets. The company's nutritional products aim to eradicate early life and maternal malnutrition by providing low-cost and convenient options to families with limited income and a lack of access to healthcare, transportation. | ||||||
ChromaCode is a Carlsbad, California-based company developing molecular diagnostics and bioinformatics systems. | ||||||
Memo Therapeutics is an antibody Discovery Technology founded in 2012. | ||||||
Antiviral therapy | ||||||
MinervaX is a Copenhagen-based company founded in 2010 by Per Fischer. | ||||||
Boulder-based biotech company specializing in microarray technology and applications | ||||||
AN2 is a novel medicines targeting infectious diseases founded by Eric Easom. | ||||||
LimmaTech Biologics is a Switzerland-based company founded in 2015. | ||||||
Curevo Vaccine is a company founded in 2018. | ||||||
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases. | ||||||
hermostabilization and Atomic Layer Deposition methods for Vaccine Formulation |
